Name | sb-423557 |
---|
Description | SB-423557 is an orally active calcium-sensing receptor (CaR) antagonist (IC50=520 nM), precursor of SB-423562 (IC50=73 nM). SB-423557 is well tolerated in human and increases plasma concentrations of exogenous parathyroid hormone (PTH) and stimulates bone formation[1]. |
---|---|
Related Catalog | |
Target |
IC50: 520 nM (Calcium-sensing receptor)[1] |
In Vivo | SB-423557 (oral administration; 10, 30 or 100 μM/kg; once daily; 12 weeks) elicits transient increases in plasma concentrations of PTH, resulting in increased bone mass and strength in both vertebrae and long bones compared to that of OVX controls[1]. |
References |
Molecular Formula | C28H36N2O4 |
---|---|
Molecular Weight | 464.59600 |
Exact Mass | 464.26800 |
PSA | 91.58000 |
LogP | 4.35788 |
Precursor 0 | |
---|---|
DownStream 1 | |